Australian vaccine preventable disease epidemiological review series: mumps 2008-2012

Shopna K Bag1, Aditi Dey1, Han Wang1

  • 1National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and the University of Sydney, Westmead, New South Wales.

Insights

Mumps notifications in Australia decreased then increased, with a concerning rise in vaccinated individuals. Better vaccination data is crucial for monitoring vaccine effectiveness and potential mumps elimination.

Area of Science:

  • Epidemiology
  • Infectious Disease Surveillance
  • Public Health

Background:

  • Australia experienced a notable increase in mumps notifications in 2007, with outbreaks in Western Australia and the Northern Territory.
  • A significant concern was the occurrence of mumps cases in individuals who had been vaccinated.

Purpose of the Study:

  • To analyze epidemiological data on mumps in Australia from 2008 to 2012.
  • To assess trends in mumps notifications, hospitalizations, and mortality.
  • To identify demographic patterns and inform strategies for mumps control.

Main Methods:

  • Utilized data from the National Notifiable Diseases Surveillance System, National Hospital Morbidity Database, and Australian Bureau of Statistics (ABS).
  • Analyzed notification, hospitalization, and mortality data from 2008-2012 (notifications) and 2008-2011 (hospitalizations/deaths) by age, year, and jurisdiction.
  • Calculated rates using ABS population data.

Main Results:

  • National mumps notification rates declined from 1.3/100,000 in 2008 to 0.4/100,000 in 2010, then rose to 0.9/100,000 in 2012, driven by New South Wales.
  • Hospitalization rates remained stable at 0.4/100,000 between 2008-2011.
  • The median age for cases and hospitalizations was 30 and 27 years, respectively, with the 25-34 age group most affected. Vaccination status completeness was low (16%-39%).

Conclusions:

  • The increasing trend in mumps notifications requires close monitoring.
  • Improved data quality, particularly regarding vaccination status, is essential for evaluating vaccine effectiveness.
  • Enhanced case history and genotyping data are needed to assess Australia's progress toward mumps elimination.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.3K
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
56
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
133
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
61
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
51